Patent AnalyticsExaminers
Rankings

Law firm or agent

Sughrue Mion/IMMUNOGEN

20 applicationsfiled 2007 to 2012

Allowance rate
45%
−30 pts vs the USPTO range 26% to 66%
Rejections before allowance
1.8
+0.2 vs the USPTO
Months to first action
17.7 mo
−0.9 vs the USPTO
Needed an RCE
20%
−7 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations8 apps
C07K Peptides5 apps
C07D Heterocyclic compounds4 apps
A01K 2 apps
C07H 1 apps

Art units

16439 apps
16286 apps
16422 apps
16912 apps
16441 apps

Who they file for

Clients with the most applications

Bars show the share of decided applications that were allowed.

Unlock the clients they file forIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
13616832ANTI-IGF-I RECEPTOR ANTIBODIES, DNAS, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS2012-09-14Abandoned0024.5 mo
13469550METHOD OF TARGETING SPECIFIC CELL POPULATIONS USING CELL-BINDING AGENT MAYTANSINOID…2012-05-11Abandoned105.8 mo
13305042METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES2011-11-28Abandoned1018.5 mo
15212284Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15770036Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15206324Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15409615Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15215009Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15727956Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15712147Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 20 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in